Alzheimer’s Drug Discovery Foundation Invests in First-of-its-Kind Biomarker Observatory Led by Renowned Clinical Trials Expert to Accelerate Novel Drug Development

Alzheimer’s Drug Discovery Foundation Invests in First-of-its-Kind Biomarker Observatory Led by Renowned Clinical Trials Expert to Accelerate Novel Drug Development The Alzheimer’s Drug Discovery Foundation (ADDF) has recently announced a groundbreaking investment aimed at revolutionizing the landscape of Alzheimer’s research and drug development. This investment is directed towards the creation of a first-of-its-kind biomarker observatory, […]